NYSE: AFLAflac

    Aflac Q3 2026 Results: Net Income $303 Million on Revenue of $3.27 Billion

    • US stocks
    • Earnings
    • Financials

    Aflac (NYSE: AFL) reported third quarter 2026 GAAP revenue of $3.27 billion and GAAP net income of $303 million, it said on 4 Nov 2026. Diluted EPS was $0.61 on a GAAP basis, and the company's adjusted EPS, a company-defined measure that excludes net investment gains and losses and some other items, was $2.43.

    Key highlights

    • Revenue (GAAP): $3.27 billion, down 31.0% YoY and 20.5% QoQ
    • Net income (GAAP): $303.0 million, down 81.5% YoY and 63.3% QoQ
    • Diluted EPS (GAAP): $0.61, down 80.2% YoY and 62.6% QoQ
    • Adjusted EPS (company-defined): $2.43, down 2.4% YoY
    • Shareholder returns: $1.1 billion, including $804 million of share repurchases and $305 million of dividends

    Summary

    Consolidated (GAAP) $ million
    ParticularsQ3 2026Q3 2025YoYQ2 2026QoQ
    Revenue3,271.04,740.0-31.0%4,117.0-20.5%
    303.01,639.0-81.5%825.0-63.3%
    Diluted EPS ($)0.613.08-80.2%1.63-62.6%

    Figures are in $ million except EPS; YoY compares with Q3 2025 and QoQ with Q2 2026. Q3 2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are checked against the company's SEC XBRL filings. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.

    The table shows GAAP revenue of $3.27 billion, down 31.0% from a year earlier and 20.5% from the second quarter of 2026. Net income was 9.3% of revenue this quarter, against 34.6% a year earlier, 25.3 percentage points lower.

    GAAP diluted EPS was $0.61, against $3.08 a year earlier and $1.63 in the second quarter of 2026.

    Adjusted figures exclude net investment losses

    Adjusted earnings, a company-defined measure, were $1,214 million, against $1,327 million a year earlier, a decrease of 8.5%. The company's reconciliation adds back items such as net investment losses and a tax valuation allowance. Adjusted EPS was $2.43, down 2.4%.

    Net investment losses were $1.1 billion, or $2.15 per diluted share, against net investment gains of $275 million a year earlier. The company said the losses included net losses from sales and redemptions of $842 million.

    The company said adjusted earnings benefited from reserve remeasurement gains of $453 million. It also said the weaker yen/dollar rate reduced adjusted EPS by $0.03, and before that current period effect the figure was $2.46.

    Aflac U.S. pretax adjusted earnings rose 31.5%

    Aflac U.S. pretax adjusted earnings were $493 million, up 31.5% from $375 million, and its pretax adjusted profit margin was 27.7%, against 21.7% a year earlier. The company said the increase was primarily driven by lower benefits from higher reserve remeasurement gains, higher premiums and lower expenses.

    Aflac Japan pretax adjusted earnings were $961 million, down 21.0% from $1,216 million, and ¥152.3 billion in yen terms, down 15.2% on a reported basis. The company said the decline was primarily driven by higher benefits from lower reserve remeasurement gains from unlocking actuarial assumptions.

    Aflac Japan new annualized premium sales fell 4.0% to ¥18.8 billion, or $118 million. The company said this reflected high prior-year sales of Miraito cancer insurance, partly offset by growth in Tsumitasu and Anshin Palette.

    Inference

    The company returned $1.1 billion to shareholders in the quarter, including $804 million of share repurchases and $305 million of dividends. Diluted shares used in the quarter were 498,684 thousand, against 532,015 thousand a year earlier. The board declared a fourth quarter dividend of $0.61 per share, payable on 1 Dec 2026 to holders of record at the close of business on 18 Nov 2026, which the company said extends its 44 consecutive years of dividend increases.

    The release does not give full-year 2026 guidance or the number of shares repurchased in the quarter. The next dated step it names is the dividend payment on 1 Dec 2026.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts